Biohaven Pharmaceutical Holding Co. Ltd.(NYSE : BHVN)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.14% | 148.45 | 0.7% | $817.55m | |
| BMY | Bristol-Myers Squibb Co. | -0.82% | 66.88 | 1.0% | $766.87m | |
| PFE | Pfizer Inc. | 1.29% | 40.71 | 0.9% | $619.15m | |
| MRK | Merck & Co., Inc. | -1.26% | 88.52 | 0.7% | $606.57m | |
| ABBV | AbbVie, Inc. | -2.23% | 85.27 | 2.3% | $577.01m | |
| LLY | Eli Lilly & Co. | -0.27% | 141.18 | 1.1% | $410.25m | |
| NVS | Novartis AG | -0.31% | 94.92 | 0.2% | $122.34m | |
| APLS | Apellis Pharmaceuticals, Inc. | -0.42% | 42.29 | 0.0% | $116.99m | |
| GSK | GlaxoSmithKline Plc | 0.08% | 47.83 | 0.2% | $97.55m | |
| AZN | AstraZeneca Plc | -0.48% | 50.21 | 1.2% | $92.99m | |
| KRTX | Karuna Therapeutics, Inc. | -13.46% | 99.75 | 0.0% | $72.42m | |
| NVO | Novo Nordisk A/S | 0.46% | 61.60 | 0.1% | $67.09m | |
| SNY | Sanofi | 0.41% | 49.60 | 0.2% | $61.96m | |
| RETA | Reata Pharmaceuticals, Inc. | -1.40% | 206.82 | 3.5% | $61.74m | |
| ENDP | Endo International Plc | 4.35% | 6.60 | 8.8% | $47.74m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.